Hormonal and barrier contraception and risk of upper genital tract disease in the PID Evaluation and Clinical Health (PEACH) study

Roberta B. Ness, David E. Soper, Robert L. Holley, Jeffrey Peipert, Hugh Randall, Richard L Sweet, Steven J. Sondheimer, Susan L. Hendrix, Antonio Amortegui, Giuliana Trucco, Debra C. Bass, Sheryl F. Kelsey

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

OBJECTIVE: Among women diagnosed with pelvic inflammatory disease, we examined the associations between hormonal or barrier methods of contraception and upper genital tract infection or inflammation. METHODS: Participants were 563 patients from a treatment trial for pelvic inflammatory disease. All had pelvic pain; pelvic organ tenderness; and leukorrhea, mucopurulent cervicitis, or untreated cervicitis. Contraceptive use within the prior 4 weeks was compared among women with baseline upper genital tract gonorrhea or chlamydia, women with endometritis without upper genital tract gonorrhea or chlamydia, and women with neither upper genital tract gonorrhea or chlamydia nor endometritis. RESULTS: Inconsistent condom use was significantly and independently associated with a 2 to 3 times elevated risk for upper genital tract infection. Upper genital tract gonorrhea or chlamydia was not significantly associated with use of oral contraceptives, use of medroxyprogesterone, condoms used consistently, nor other barrier methods. CONCLUSION: No hormonal or barrier contraceptive method was related to a reduction in upper genital tract disease among women with clinical pelvic inflammatory diseases.

Original languageEnglish (US)
Pages (from-to)121-127
Number of pages7
JournalAmerican Journal of Obstetrics and Gynecology
Volume185
Issue number1
DOIs
StatePublished - 2001
Externally publishedYes

Fingerprint

Barrier Contraception
Chlamydia
Gonorrhea
Pelvic Inflammatory Disease
Uterine Cervicitis
Reproductive Tract Infections
Health
Endometritis
Condoms
Leukorrhea
Medroxyprogesterone
Pelvic Pain
Oral Contraceptives
Contraceptive Agents
Clinical Studies
Inflammation

ASJC Scopus subject areas

  • Medicine(all)
  • Obstetrics and Gynecology

Cite this

Hormonal and barrier contraception and risk of upper genital tract disease in the PID Evaluation and Clinical Health (PEACH) study. / Ness, Roberta B.; Soper, David E.; Holley, Robert L.; Peipert, Jeffrey; Randall, Hugh; Sweet, Richard L; Sondheimer, Steven J.; Hendrix, Susan L.; Amortegui, Antonio; Trucco, Giuliana; Bass, Debra C.; Kelsey, Sheryl F.

In: American Journal of Obstetrics and Gynecology, Vol. 185, No. 1, 2001, p. 121-127.

Research output: Contribution to journalArticle

Ness, RB, Soper, DE, Holley, RL, Peipert, J, Randall, H, Sweet, RL, Sondheimer, SJ, Hendrix, SL, Amortegui, A, Trucco, G, Bass, DC & Kelsey, SF 2001, 'Hormonal and barrier contraception and risk of upper genital tract disease in the PID Evaluation and Clinical Health (PEACH) study', American Journal of Obstetrics and Gynecology, vol. 185, no. 1, pp. 121-127. https://doi.org/10.1067/mob.2001.115114
Ness, Roberta B. ; Soper, David E. ; Holley, Robert L. ; Peipert, Jeffrey ; Randall, Hugh ; Sweet, Richard L ; Sondheimer, Steven J. ; Hendrix, Susan L. ; Amortegui, Antonio ; Trucco, Giuliana ; Bass, Debra C. ; Kelsey, Sheryl F. / Hormonal and barrier contraception and risk of upper genital tract disease in the PID Evaluation and Clinical Health (PEACH) study. In: American Journal of Obstetrics and Gynecology. 2001 ; Vol. 185, No. 1. pp. 121-127.
@article{2c7f2b2f4c49431fa512c5c3979483a4,
title = "Hormonal and barrier contraception and risk of upper genital tract disease in the PID Evaluation and Clinical Health (PEACH) study",
abstract = "OBJECTIVE: Among women diagnosed with pelvic inflammatory disease, we examined the associations between hormonal or barrier methods of contraception and upper genital tract infection or inflammation. METHODS: Participants were 563 patients from a treatment trial for pelvic inflammatory disease. All had pelvic pain; pelvic organ tenderness; and leukorrhea, mucopurulent cervicitis, or untreated cervicitis. Contraceptive use within the prior 4 weeks was compared among women with baseline upper genital tract gonorrhea or chlamydia, women with endometritis without upper genital tract gonorrhea or chlamydia, and women with neither upper genital tract gonorrhea or chlamydia nor endometritis. RESULTS: Inconsistent condom use was significantly and independently associated with a 2 to 3 times elevated risk for upper genital tract infection. Upper genital tract gonorrhea or chlamydia was not significantly associated with use of oral contraceptives, use of medroxyprogesterone, condoms used consistently, nor other barrier methods. CONCLUSION: No hormonal or barrier contraceptive method was related to a reduction in upper genital tract disease among women with clinical pelvic inflammatory diseases.",
author = "Ness, {Roberta B.} and Soper, {David E.} and Holley, {Robert L.} and Jeffrey Peipert and Hugh Randall and Sweet, {Richard L} and Sondheimer, {Steven J.} and Hendrix, {Susan L.} and Antonio Amortegui and Giuliana Trucco and Bass, {Debra C.} and Kelsey, {Sheryl F.}",
year = "2001",
doi = "10.1067/mob.2001.115114",
language = "English (US)",
volume = "185",
pages = "121--127",
journal = "American Journal of Obstetrics and Gynecology",
issn = "0002-9378",
publisher = "Mosby Inc.",
number = "1",

}

TY - JOUR

T1 - Hormonal and barrier contraception and risk of upper genital tract disease in the PID Evaluation and Clinical Health (PEACH) study

AU - Ness, Roberta B.

AU - Soper, David E.

AU - Holley, Robert L.

AU - Peipert, Jeffrey

AU - Randall, Hugh

AU - Sweet, Richard L

AU - Sondheimer, Steven J.

AU - Hendrix, Susan L.

AU - Amortegui, Antonio

AU - Trucco, Giuliana

AU - Bass, Debra C.

AU - Kelsey, Sheryl F.

PY - 2001

Y1 - 2001

N2 - OBJECTIVE: Among women diagnosed with pelvic inflammatory disease, we examined the associations between hormonal or barrier methods of contraception and upper genital tract infection or inflammation. METHODS: Participants were 563 patients from a treatment trial for pelvic inflammatory disease. All had pelvic pain; pelvic organ tenderness; and leukorrhea, mucopurulent cervicitis, or untreated cervicitis. Contraceptive use within the prior 4 weeks was compared among women with baseline upper genital tract gonorrhea or chlamydia, women with endometritis without upper genital tract gonorrhea or chlamydia, and women with neither upper genital tract gonorrhea or chlamydia nor endometritis. RESULTS: Inconsistent condom use was significantly and independently associated with a 2 to 3 times elevated risk for upper genital tract infection. Upper genital tract gonorrhea or chlamydia was not significantly associated with use of oral contraceptives, use of medroxyprogesterone, condoms used consistently, nor other barrier methods. CONCLUSION: No hormonal or barrier contraceptive method was related to a reduction in upper genital tract disease among women with clinical pelvic inflammatory diseases.

AB - OBJECTIVE: Among women diagnosed with pelvic inflammatory disease, we examined the associations between hormonal or barrier methods of contraception and upper genital tract infection or inflammation. METHODS: Participants were 563 patients from a treatment trial for pelvic inflammatory disease. All had pelvic pain; pelvic organ tenderness; and leukorrhea, mucopurulent cervicitis, or untreated cervicitis. Contraceptive use within the prior 4 weeks was compared among women with baseline upper genital tract gonorrhea or chlamydia, women with endometritis without upper genital tract gonorrhea or chlamydia, and women with neither upper genital tract gonorrhea or chlamydia nor endometritis. RESULTS: Inconsistent condom use was significantly and independently associated with a 2 to 3 times elevated risk for upper genital tract infection. Upper genital tract gonorrhea or chlamydia was not significantly associated with use of oral contraceptives, use of medroxyprogesterone, condoms used consistently, nor other barrier methods. CONCLUSION: No hormonal or barrier contraceptive method was related to a reduction in upper genital tract disease among women with clinical pelvic inflammatory diseases.

UR - http://www.scopus.com/inward/record.url?scp=0034925420&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034925420&partnerID=8YFLogxK

U2 - 10.1067/mob.2001.115114

DO - 10.1067/mob.2001.115114

M3 - Article

C2 - 11483915

AN - SCOPUS:0034925420

VL - 185

SP - 121

EP - 127

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

SN - 0002-9378

IS - 1

ER -